Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29056320.
- Also identified by DOI 10.1016/j.ypmed.2017.09.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Invited editorial for PM 17 348R2, a CDC survey regarding primary HPV testing.
Medical subject headings
- Early Detection of Cancer
- Mass Screening
- Papillomavirus Infections
- Uterine Cervical Neoplasms